Studies of the HER-2 / neu proto-oncogene in human breast and ovarian cancer .Randomized phase Ⅱ trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast c ......